Open Demo Account
Home / Market Update / Gilead Sciences: We’ll Be Able to Make Enough Remdesivir in October

Gilead Sciences: We’ll Be Able to Make Enough Remdesivir in October

Adel 7 August, 2020 1:17 pm Market Update

Biotech company Gilead Sciences said it will be able to produce enough anti-coronavirus drug Remdesivir to meet global demand in October.

In addition, Gilead said it plans to produce more than 2 million “treatment courses” for the drug by the end of the year, and expects to be able to produce “several million more” in 2021.

The company also added that it has increased the supply of the drug more than 50-fold since January.

Tags

Check Also

Gold Prices Continue Climb on Rate Cut Expectations, Awaiting Payrolls Data

Gold prices continued their upward trajectory in Asian trading on Friday, building on recent gains …

This site contains information and opinions for the purpose of providing only general information and can not be relied upon. The information and opinions contained in this Site shall in no way constitute an offer or solicitation to buy, sell or subscribe to any investment product. Users of this site shall bear any risks arising from the use of any information, opinion, program, service or material. Noor Trends reserves the right to make any change to the Site, the information, opinions, materials, products, programs, services or prices (if any) at any time without notice.
All copyrights reserved Noor Trends